Cytomegalovirus retinitis and FK 506

American Journal of Ophthalmology

Volumn 136, Issue 2, 2003, Pages 386-389

  Ciardella, Antonio P ^a,b   Barile, Gaetano ^a   Langton, Kevin ^a   Chang, Stanley ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b NewYork Presbyterian Columbia University Irving Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS; DISEASE COURSE; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REMISSION; RETINA DISEASE; RETINITIS; RETROSPECTIVE STUDY; SLOW RELEASE FORMULATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0042850359     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(03)00232-0     Document Type: Article

References (4)

1. Kino T., Hatanaka H., Hashmoto M., et al. FK 506 a novel immunosuppressant isolated from streptomyces I. Termination, isolation and physicochemical and biological characteristics . J Antibiot. 40:1987;1249-1255.
2. Goto T., Kino T., Hatanaka H., et al. FK 506 historical perspectives . Transplant Proc. 23:1991;2713-2717.
3. Hadley S., Samore M.H., Lewis W.D., Jenkins R.L., Karchmer A.W., Hammer S.M. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK 506 as primary immunosuppression. Transplantation. 59:1995;851-859.
4. Paul A.A., Leeper H.F., Friberg T.R. CMV retinitis and the use of FK 506. Transplant Proc. 23:1991;3042-3043.